IP Library › Granted Patent US 12,668,834
Granted Patent B2
US 12,668,834 · App. 18/145,007 · Granted Jun 30, 2026

Strand displacing amplification enzymes

Inventors: Souad Naji (La Jolla, CA); Eli N. Glezer (Del Mar, CA); Bruna Krebs Kutche (San Diego, CA); Ali Nikoomanzar (San Diego, CA); Alexander Sevy (San Diego, CA); Caleb Newman (San Diego, CA); Ryan Shultzaberger (San Diego, CA); Abrehet Abdu (San Diego, CA); Youngjin Cho (San Diego, CA); Janell J. Kosmatka (Encinitas, CA)
Assignee: Singular Genomics Systems, Inc.
C12Q1/6844C12N9/1247C12Q1/6811
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,668,834
App. No.
18/145,007
Granted
Jun 30, 2026
Kind
B2
Abstract

Disclosed herein, inter alia, are novel strand-displacing polymerases and methods of use thereof.

Claims (55)

1 . A polymerase comprising an amino acid sequence that is at least 80% identical to a contiguous 500 amino acid sequence within SEQ ID NO: 1; comprising

a first substitution at amino acid position 588 or an amino acid position corresponding to position 588; wherein the first substitution is leucine, isoleucine, valine, alanine, or glycine; and

a second substitution:

at amino acid position 7 or an amino acid position corresponding to position 7, wherein the second substitution is histidine, lysine, or arginine;

at amino acid position 97 or an amino acid position corresponding to position 97, wherein the second substitution is cysteine, histidine, lysine, serine, threonine, or methionine; or

at amino acid position 742 or an amino acid position corresponding to position 742, wherein the second substitution is leucine, isoleucine, alanine, or glycine.

2 . The polymerase of claim 1 , wherein the second substitution is a substitution at amino acid position 7 or an amino acid position corresponding to position 7, wherein the substitution is histidine, lysine, or arginine.

3 . The polymerase of claim 2 , further comprising a substitution at amino acid position 742 or an amino acid position corresponding to position 742, wherein the substitution is leucine, isoleucine, alanine, or glycine.

4 . The polymerase of claim 1 , wherein the second substitution is a substitution at amino acid position 97 or an amino acid position corresponding to position 97, wherein the substitution is cysteine, histidine, lysine, serine, threonine, or methionine.

5 . The polymerase of claim 4 , further comprising a substitution at amino acid position 742 or an amino acid position corresponding to position 742, wherein the substitution is leucine, isoleucine, alanine, or glycine.

6 . The polymerase of claim 1 , wherein the second substitution is a substitution at amino acid position 742 or an amino acid position corresponding to position 742, wherein the substitution is leucine, isoleucine, alanine, or glycine.

7 . The polymerase of claim 1 , comprising a substitution at amino acid position 13 or an amino acid position corresponding to position 13, wherein the substitution is arginine, isoleucine, methionine, or histidine.

8 . The polymerase of claim 1 , wherein the second substitution is a substitution at amino acid position 97 or an amino acid position corresponding to position 97, wherein the substitution is cysteine or histidine.

9 . The polymerase of claim 1 , wherein the first substitution is leucine, isoleucine, valine, or alanine.

10 . The polymerase of claim 1 , wherein the first substitution is leucine or valine.

11 . The polymerase of claim 1 , comprising a substitution at amino acid position 579 or an amino acid position corresponding to position 579, wherein the substitution is alanine or glycine.

12 . The polymerase of claim 1 , comprising a substitution at amino acid position 726 or an amino acid position corresponding to amino acid position 726, wherein the substitution is aspartic acid, glutamic acid, asparagine, or glutamine.

13 . The polymerase of claim 1 , comprising a substitution at amino acid position 13 or an amino acid position corresponding to position 13, wherein the substitution is arginine, leucine, isoleucine, or histidine.

14 . The polymerase of claim 1 , comprising:

a substitution at amino acid position 13 or an amino acid position corresponding to position 13, wherein the substitution is arginine, leucine, isoleucine, or histidine; and

a substitution at amino acid position 579 or an amino acid position corresponding to position 579, wherein the substitution is alanine or glycine.

15 . The polymerase of claim 1 , comprising:

R97H, F588L, G635D, and V742A;

K13R, R97C, E579G, and F588L;

R97C, E563G, E579G, F588L, and V742A;

R97H, F588L, and G635D;

R97C, F588L, and V742A;

Y7H, K13I, E579G, F588L, and V742A;

Y7H, K13R, R97H, and V742A;

Y7H, K13R, R97C, D141A, E579G, F588L, and V742A;

R97C, E579G, F588L, and V742A;

Y7H, R97C, E579G, and F588L;

Y7H, R97C, and V742A; or

Y7H, K13R, E563G, F588L, and V742A.

16 . The polymerase of claim 1 , comprising:

E29D, Y30F, R97H, I160V, K229E, A511V, 1548V, F588L, G635D, and V742A;

K13R, R32H, F75L, R97C, K201I, Y209H, 1256V, Y291H, E383D, G400D, R526C, E579G, F588L, E638G, and A730V;

F75L, R97C, I142T, V278I, A281T, A292E, M329L, P372S, H440N, E563G, E579G, F588L, D729Y, and V742A;

I65V, R97H, F283S, V308M, K465E, F588L, T591A, I604M, G635D, and K727T;

E25K, R97C, A168T, R255H, F326Y, K478R, R526H, E556K, K558N, P573S, E581N, F588L, E600K, E601K, R686H, R724H, V742A, K752E, and K762N;

Y7H, K13I, F75L, R97L, I160V, V170I, A316P, K469E, A491V, E579G, F588L, V637D, H726D, and V742A;

Y7H, K13R, A40V, R97H, F116L, A117S, K154E, A281T, I415V, K477I, K552N, N569S, E577K, A585G, F588I, E655D, and V742A;

Y7H, K13R, I38F, A40V, R97C, D141A, P286L, G350S, R467C, and K469T, E579G, F588L, F721Y, H726D, V742A, L756C, R757A, W758G, Q759R, T761P, K762N, Q763R, V764L, and G765V;

V63A, F75L, R97C, D98G, R188H, F214I, G245S, D246E, T319I, G350S, E579G, F588L, R690H, H726D, V742A, and K760N;

Y7H, I18V, R97C, A168S, F214S, G284S, P286Q, A292V, G304D, K391I, E431D, K477I, Y567H, E579G, F588L, and H726D;

Y7H, 18V, N23D, V66A, F75L, R97C, P217Q, A298S, A316P, K465E, R526H, E577K, E601D, T606I, E655D, R706C, V742A, and W769S; or

Y7H, K13R, L76P, K192E, K289T, R364C, L397M, Q484H, E563G, F588L, V637D, R706H, V742A, and L766P.

17 . The polymerase of claim 1 , further comprising an alanine at amino acid position 141 or an amino acid position corresponding to position 141; and an alanine at amino acid position 143 or an amino acid position corresponding to position 143.

18 . A method of incorporating a nucleotide into a nucleic acid sequence comprising combining in a reaction vessel: (i) a nucleic acid template, (ii) a nucleotide solution, and (iii) a polymerase, wherein the polymerase is a polymerase of claim 1 .

19 . A method of amplifying a nucleic acid sequence comprising:

a. hybridizing a nucleic acid template with a primer to form a primer-template hybridization complex;

b. contacting the primer-template hybridization complex with a DNA polymerase and a plurality of nucleotides, wherein the DNA polymerase is the polymerase of claim 1 ;

c. incorporating one or more nucleotides into the primer-template hybridization complex with the DNA polymerase to generate amplification products, thereby amplifying a nucleic acid sequence.

20 . A kit comprising the polymerase of claim 1 .

21 . The polymerase of claim 1 , comprising an amino acid sequence that is 85% identical to SEQ ID NO: 1.

Assignments (2)
SECURITY INTEREST Recorded Mar 7, 2025
From: SINGULAR GENOMICS SYSTEMS, INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 070440/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2023
From: NAJI, SOUAD; GLEZER, ELI N.; KUTCHE, BRUNA KREBS; NIKOOMANZAR, ALI; SEVY, ALEXANDER; NEWMAN, CALEB; SHULTZABERGER, RYAN; ABDU, ABREHET; CHO, YOUNGJIN; KOSMATKA, JANELL J.
To: SINGULAR GENOMICS SYSTEMS, INC
Reel/Frame 062481/0805 →
Continuity (2)
Provisional Application 63292890 · Dec 22, 2021
Related Publication 20230257803A1 · Aug 17, 2023
References Cited (123)
US 4318846A · Khanna et al. · 1982 [cited by applicant]
US 5034506A · Summerton et al. · 1991 [cited by applicant]
US 5066580A · Lee · 1991 [cited by applicant]
US 5188934A · Menchen et al. · 1993 [cited by applicant]
US 5235033A · Summerton et al. · 1993 [cited by applicant]
US 5366860A · Bergot et al. · 1994 [cited by applicant]
US 5599675A · Brenner · 1997 [cited by applicant]
US 5688648A · Mathies et al. · 1997 [cited by applicant]
US 5750341A · Macevicz · 1998 [cited by applicant]
US 5756334A · Perler et al. · 1998 [cited by applicant]
US 5763954A · Hiatt et al. · 1998 [cited by applicant]
US 5800996A · Lee et al. · 1998 [cited by applicant]
US 5808045A · Hiatt et al. · 1998 [cited by applicant]
US 5847162A · Lee et al. · 1998 [cited by applicant]
US 5872244A · Hiatt et al. · 1999 [cited by applicant]
US 6210891B1 · Nyren et al. · 2001 [cited by applicant]
US 6232465B1 · Hiatt et al. · 2001 [cited by applicant]
US 6258568B1 · Nyren · 2001 [cited by applicant]
US 6274320B1 · Rothberg et al. · 2001 [cited by applicant]
US 6465254B1 · Saito et al. · 2002 [cited by applicant]
US 6664079B2 · Ju et al. · 2003 [cited by applicant]
US 7057026B2 · Barnes et al. · 2006 [cited by applicant]
US 7541170B2 · Wang et al. · 2009 [cited by applicant]
US 7541444B2 · Milton et al. · 2009 [cited by applicant]
US 8114973B2 · Siddiqi et al. · 2012 [cited by applicant]
US 8178360B2 · Barnes et al. · 2012 [cited by applicant]
US 10041115B2 · Stupi et al. · 2018 [cited by applicant]
US 10738072B1 · Graham et al. · 2020 [cited by applicant]
US 11034942B1 · Naji et al. · 2021 [cited by applicant]
US 11136565B2 · Naji et al. · 2021 [cited by applicant]
US 11174281B1 · Graham et al. · 2021 [cited by applicant]
US 11845923B2 · Naji et al. · 2023 [cited by applicant]
US 11851687B2 · Naji et al. · 2023 [cited by applicant]
US 11884943B2 · Naji et al. · 2024 [cited by applicant]
US 11891633B2 · Naji et al. · 2024 [cited by applicant]
US 12344867B2 · Naji et al. · 2025 [cited by applicant]
US 12454683B2 · Naji et al. · 2025 [cited by applicant]
US 20040191825A1 · Wang et al. · 2004 [cited by applicant]
US 20050266439A1 · Hjorleifsdottir et al. · 2005 [cited by applicant]
US 20060240439A1 · Smith et al. · 2006 [cited by applicant]
US 20110045489A1 · Gardner et al. · 2011 [cited by applicant]
US 20130012399A1 · Myers et al. · 2013 [cited by applicant]
US 20150140561A1 · Bergmann et al. · 2015 [cited by applicant]
US 20160090579A1 · Bomati et al. · 2016 [cited by applicant]
US 20170022553A1 · Vijayan et al. · 2017 [cited by applicant]
US 20170130051A1 · Marma et al. · 2017 [cited by applicant]
US 20170298327A1 · Bomati et al. · 2017 [cited by applicant]
US 20190048404A1 · Dambacher · 2019 [cited by applicant]
US 20200080065A1 · Fuller et al. · 2020 [cited by applicant]
US 20230011240A1 · Fuller et al. · 2023 [cited by applicant]
US 20230203578A1 · Naji et al. · 2023 [cited by applicant]
US 20230257803A1 · Naji et al. · 2023 [cited by applicant]
US 20240200041A1 · Naji et al. · 2024 [cited by applicant]
WO 1989010977A1 · 1989 [cited by applicant]
WO 1996007669A1 · 1996 [cited by applicant]
WO 2004018497A2 · 2004 [cited by applicant]
WO 2005024010A1 · 2005 [cited by applicant]
WO 2009131919A1 · 2009 [cited by applicant]
WO 2015148402A1 · 2015 [cited by applicant]
WO 2017058953A1 · 2017 [cited by applicant]
WO 2017205336A1 · 2017 [cited by applicant]
WO 2018148723A1 · 2018 [cited by applicant]
WO 2019164977A1 · 2019 [cited by applicant]
WO 2020056044A1 · 2020 [cited by applicant]
WO 2021173711A2 · 2021 [cited by applicant]
Abil, Z. et al. (Apr. 9, 2018, e-published Mar. 2018). “Compartmentalized Self-Replication for Evolution of a DNA Polymerase,” [cited by applicant]
Bentley, D. R. et al. (Nov. 6, 2008). “Accurate whole human genome sequencing using reversible terminator chemistry,” [cited by applicant]
Bergen, K. et al. (Jun. 17, 2013, e-published Jun. 3, 2013). “Structures of KOD and 9ºN DNA polymerases complexed with primer template duplex,” Chembiochem 14(9): 1058-1062. [cited by applicant]
Buchfink, B. et al. (Jan. 2015, e-published Nov. 17, 2014). “Fast and sensitive protein alignment using DIAMOND,” [cited by applicant]
Fire, A. et al. (May 9, 1995). “Rolling replication of short DNA circles,” PNAS USA 92(10): 4641-4645. [cited by applicant]
Fogg, M. J. et al. (Dec. 1, 2002, e-published Nov. 4, 2002). “Structural basis for uracil recognition by archaeal family B DNA polymerases,” [cited by applicant]
Fuller, C.W. et al. (May 10, 2016, e-published Apr. 18, 2016). “Real-time single-molecule electronic DNA sequencing by synthesis using polymer-tagged nucleotides on a nanopore array,” PNAS USA 113(19): 5233-5238. [cited by applicant]
Gibson, D. G. et al. (May 2009, e-published Apr. 12, 2009). “Enzymatic assembly of DNA molecules up to several hundred kilobases,” [cited by applicant]
Gibson, D. G. et al. (Oct. 10, 2010). “Chemical synthesis of the mouse mitochondrial genome,” [cited by applicant]
Guo, J. et al. (Jul. 8, 2008, e-published Jun. 30, 2008). “Four-color DNA sequencing with 3′- O-modified nucleotide reversible terminators and chemically cleavable fluorescent dideoxynucleotides,” PNAS USA 105(27): 9145… [cited by applicant]
Harris, C. L. et al. (Feb. 2013, e-published Apr. 3, 2018). “Polymerase chain displacement reaction,” [cited by applicant]
Kumar, S. et al. (Sep. 21, 2012). “PEG-labeled nucleotides and nanopore detection for single molecule DNA sequencing by synthesis,” [cited by applicant]
Lage, J. M. et al. (2003). “Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array—CGH,” [cited by applicant]
Lasken, R. S. et al. (Jul. 1996). “Archaebacterial DNA polymerases tightly bind uracil-containing DNA,” [cited by applicant]
Lizardi, P. M. et al. (Jul. 1998). “Mutation detection and single-molecule counting using isothermal rolling-circle amplification,” [cited by applicant]
Loeb, L. A. et al. (Aug. 2008, e-published Jul. 15, 2008). “DNA polymerases and human disease,” [cited by applicant]
Needleman, S. B. et al. (Mar. 28, 1970, e-published Oct. 28, 2004). “A general method applicable to the search for similarities in the amino acid sequence of two proteins,” [cited by applicant]
Nilsson, M. et al. (Sep. 1994). “Padlock probes: circularizing oligonucleotides for localized DNA detection,” [cited by applicant]
Nørholm, M. H. H. (Mar. 16, 2010). “A mutant Pfu DNA polymerase designed for advanced uracil-excision DNA engineering,” [cited by applicant]
Notomi, T. et al. (Jun. 15, 2000). “Loop-mediated isothermal amplification of DNA,” [cited by applicant]
Pearson, W. R. et al. (Apr. 1, 1988). “Improved tools for biological sequence comparison,” [cited by applicant]
Smith, T. F. et al. (Dec. 1981, e-published Sep. 3, 2004). “Comparison of biosequences,” [cited by applicant]
Southworth, M. W. et al. (May 28, 1996). “Cloning of thermostable DNA polymerases from hyperthermophilic marine Archaea with emphasis on [cited by applicant]
Untergasser, A. et al. (Aug. 1, 2012, e-published Jun. 22, 2012). “Primer3—new capabilities and interfaces,” [cited by applicant]
Walker, G. T. et al. (Apr. 11, 1992). “Strand displacement amplification-an isothermal, in vitro DNA amplification technique,” [cited by applicant]
Walker, G. T. et al. (Jan. 1, 1992). “Isothermal in vitro amplification of DNA by a restriction enzyme/DNA polymerase system,” [cited by applicant]
Williams, R. et al. (Jul. 2006). “Amplification of complex gene libraries by emulsion PCR,” [cited by applicant]
Xu, G. et al. (Feb. 3, 2012). “Cross priming amplification: mechanism and optimization for isothermal DNA amplification,” [cited by applicant]
Extended European Search Report issued in European Application 19859131.5, mailed on May 11, 2022, 7 pages. [cited by applicant]
Extended European Search Report issued in European Patent Application No. 21761816.4, mailed on, May 27, 2024, 10 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/US2021/019466, mailed on, Aug. 17, 2021, 11 pages. [cited by applicant]
International Search Report and Written Opinion issued in International Application No. PCT/US2019/050678, mailed on Jan. 28, 2020, 12 pages. [cited by applicant]
USPTO Sequence Alignment search for SEQ ID No. 1, performed Oct. 11, 2024, Oct. 11, 2024, 3 pages. [cited by applicant]
Aird, D. et al. (Feb. 11, 2011). “Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries,” Genome biology 12: R18, 14 pages. [cited by applicant]
Bains, W. et al. (Dec. 7, 1988). “A novel method for nucleic acid sequence determination,” Journal of Theoretical Biology 135(3): 303-307. [cited by applicant]
Drmanac, S. et al. (Jan. 1, 1998). “Accurate sequencing by hybridization for DNA diagnostics and individual genomics,” Nature Biotechnology 16(1): 54-58. [cited by applicant]
Fodor, S. P. A. et al. (Feb. 15, 1991). “Light-directed, spatially addressable parallel chemical synthesis,” Science 251(4995): 767-773. [cited by applicant]
Gueguen, Y. et al. (Dec. 20, 2001). “Characterization of two DNA polymerases from the hyperthermophilic euryarchaeon [cited by applicant]
Hutter, D. et al. (Dec. 1, 2010). “Labeled nucleoside triphosphates with reversibly terminating aminoalkoxyl groups,” Nucleosides, Nucleotides and Nucleic Acids 29(11-12): 879- 895. [cited by applicant]
Jakobsen, T. H. et al. (Jul. 22, 2013). “Complete genome sequence of the cystic fibrosis pathogen Achromobacter xylosoxidans NH44784-1996 complies with important pathogenic phenotypes,” PloS one 8(7): e68484. [cited by applicant]
Ju, J. et al. (Dec. 26, 2006). “Four-color DNA sequencing by synthesis using cleavable fluorescent nucleotide reversible terminators,” PNAS USA 103(52): 19635-19640. [cited by applicant]
Killelea, T. et al. (Jun. 14, 2011, e-published May 20, 2011). “Role of Disulfide Bridges in Archaeal Family-B DNA Polymerases,” ChemBioChem 12(9): 1330-1336. [cited by applicant]
Kisselev, L. (Jan. 2002) “Polypeptide Release Factors in Prokaryotes and Eukaryotes: Same Function, Different Structure”, Structure, 10(1):8-9. [cited by applicant]
Lizardi et al. (Jul. 19, 1998) “Mutation Detection and Single-Molecule Counting Using Isothermal Rolling—Circle Amplification”, Nature Genetics, 19(3):225-232. [cited by applicant]
Plasterer, Thomas N. (1997) “PRIMERSELECT. Primer and Probe Design”, Methods in Molecular Biology, 70:291-302. [cited by applicant]
Ronaghi, M. et al. (Nov. 1, 1996). “Real-time DNA sequencing using detection of pyrophosphate release,” Analytical Biochemistry 242(1): 84-89. [cited by applicant]
Ronaghi, M. et al. (Jul. 17, 1998). “A sequencing method based on real-time pyrophosphate,” Science 281(5375): 363-365. [cited by applicant]
Ronaghi, M. (Jan. 2001). “Pyrosequencing sheds light on DNA sequencing,” Genome Research 11(1): 3-11. [cited by applicant]
Rosenblum, B. B. et al. (Nov. 1, 1997). “New dye-labeled terminators for improved DNA sequencing patterns,” Nucleic Acids Research 25(22): 4500-4504. [cited by applicant]
Ruparel, H. et al. (Apr. 26, 2005, e-published Apr. 13, 2005). “Design and synthesis of a 3′-O-ally) photocleavable fluorescent nucleotide as a reversible terminator for DNA sequencing by synthesis,” PNAS USA 102(17): 5… [cited by applicant]
Rychlik, Wojciech (2007) “OLIGO 7 Primer Analysis Software”, Methods in Molecular Biology, 402:35-60. [cited by applicant]
Shendure, J. et al. (Sep. 9, 2005, e-published Aug. 4, 2005). “Accurate multiplex polony sequencing of an evolved bacterial genome,” Science 309(5741): 1728-1732. [cited by applicant]
Truniger et al. (Jan. 16, 2004) “Function of the C-Terminus Of @29 DNA Polymerase in DNA and Terminal Protein Binding”, Nucleic Acids Research, 32(1): 361-370. [cited by applicant]
Whisstock et al. (Aug. 2003) “Prediction of Protein Function from Protein Sequence and Structure”, Quarterly Reviews of Biophysics, 36(3):307-340. [cited by applicant]
Witkowski et al. (1999) “Conversion of a Beta-Ketoacyl Synthase to a Malonyl Decarboxylase by Replacement of the Active-Site Cysteine with Glutamine”, Biochemistry, 38(36): 11643-11650. [cited by applicant]
Wu, J. et al. (Oct. 16, 2007). “3′-O-modified nucleotides as reversible terminators for pyrosequencing,” PNAS USA 104(42): 16462-16467. [cited by applicant]
Yamaji et al. (Apr. 2015) “Mammalian Adaptive Mutations of the PA Protein of Highly Pathogenic Avian H5N1 Influenza Virus”, Journal of Virology, 89(8):4117-4125. [cited by applicant]
Zhu, Z. et al. (Aug. 25, 1994). “Directly labeled DNA probes using fluorescent nucleotides with different length linkers,” Nucleic Acids Research 22(16): 3418-3422. [cited by applicant]